glp 1 source The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review The Ultimate Guide to GLP-1:
Description
Rami Lutfi, MD, bariatric and general surgeon and medical director for bariatric and general surgery at Carrum Health This story was originally published by Parade on Feb 10, 2026, where it first appeared in the Health & Wellness section
About 26% of the metformin and 14% of the placebo groups had lost greater than or equal to 5% of their initial body weight at the end of year two
In summary, our approach demonstrates the feasibility of using peptide-mediated targeting to achieve cell-specific ionotropic receptor modulation and highlights the therapeutic potential of unimolecular mixed GLP-1 receptor agonism and NMDA receptor antagonism for safe and effective obesity treatment
The Results Only the GLP-1 groups showed a significant boost in visceral fat activity
O'Neil et al., 2018)
Intermittent fasting and bone health: a bone of contention
